JNJ
Price
$154.53
Change
-$0.39 (-0.25%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
380.22B
85 days until earnings call
SNY
Price
$52.32
Change
-$1.22 (-2.28%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
122.61B
94 days until earnings call
Ad is loading...

JNJ vs SNY

Header iconJNJ vs SNY Comparison
Open Charts JNJ vs SNYBanner chart's image
Johnson & Johnson
Price$154.53
Change-$0.39 (-0.25%)
Volume$45.36K
Capitalization380.22B
Sanofi ADS
Price$52.32
Change-$1.22 (-2.28%)
Volume$108.07K
Capitalization122.61B
JNJ vs SNY Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. SNY commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and SNY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (JNJ: $154.93 vs. SNY: $53.54)
Brand notoriety: JNJ: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 80% vs. SNY: 136%
Market capitalization -- JNJ: $380.22B vs. SNY: $122.61B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. SNY’s [@Pharmaceuticals: Major] market capitalization is $122.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 5 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • JNJ’s TA Score: 5 bullish, 5 bearish.
  • SNY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SNY is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -1.61% price change this week, while SNY (@Pharmaceuticals: Major) price change was +5.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.23%. For the same industry, the average monthly price growth was -2.27%, and the average quarterly price growth was -8.41%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 22, 2025.

SNY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.23% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than SNY($123B). JNJ has higher P/E ratio than SNY: JNJ (30.34) vs SNY (20.80). SNY YTD gains are higher at: 11.010 vs. JNJ (7.987). JNJ has higher annual earnings (EBITDA): 23.3B vs. SNY (12.6B). JNJ has more cash in the bank: 22.9B vs. SNY (8.98B). SNY has less debt than JNJ: SNY (18.4B) vs JNJ (29.3B). JNJ has higher revenues than SNY: JNJ (85.2B) vs SNY (46.4B).
JNJSNYJNJ / SNY
Capitalization380B123B309%
EBITDA23.3B12.6B185%
Gain YTD7.98711.01073%
P/E Ratio30.3420.80146%
Revenue85.2B46.4B184%
Total Cash22.9B8.98B255%
Total Debt29.3B18.4B159%
FUNDAMENTALS RATINGS
JNJ vs SNY: Fundamental Ratings
JNJ
SNY
OUTLOOK RATING
1..100
7361
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
2336
SMR RATING
1..100
4578
PRICE GROWTH RATING
1..100
5056
P/E GROWTH RATING
1..100
6043
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (11) in the Pharmaceuticals Major industry is in the same range as JNJ (18). This means that SNY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (23) in the Pharmaceuticals Major industry is in the same range as SNY (36). This means that JNJ’s stock grew similarly to SNY’s over the last 12 months.

JNJ's SMR Rating (45) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNY (78). This means that JNJ’s stock grew somewhat faster than SNY’s over the last 12 months.

JNJ's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as SNY (56). This means that JNJ’s stock grew similarly to SNY’s over the last 12 months.

SNY's P/E Growth Rating (43) in the Pharmaceuticals Major industry is in the same range as JNJ (60). This means that SNY’s stock grew similarly to JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJSNY
RSI
ODDS (%)
Bullish Trend 6 days ago
49%
Bullish Trend 6 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
44%
Bearish Trend 6 days ago
40%
Momentum
ODDS (%)
Bullish Trend 6 days ago
45%
Bullish Trend 6 days ago
55%
MACD
ODDS (%)
Bullish Trend 6 days ago
43%
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
42%
Bullish Trend 6 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
42%
Bearish Trend 6 days ago
40%
Advances
ODDS (%)
Bullish Trend 11 days ago
40%
Bullish Trend 6 days ago
53%
Declines
ODDS (%)
Bearish Trend 20 days ago
42%
Bearish Trend 12 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
48%
Bullish Trend 6 days ago
53%
Aroon
ODDS (%)
Bearish Trend 6 days ago
32%
Bearish Trend 6 days ago
49%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.29%
PFE - JNJ
54%
Loosely correlated
+1.74%
NVS - JNJ
48%
Loosely correlated
+0.94%
GSK - JNJ
46%
Loosely correlated
+1.27%
ABBV - JNJ
41%
Loosely correlated
+1.88%
GILD - JNJ
41%
Loosely correlated
-0.22%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with GSK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+0.98%
GSK - SNY
41%
Loosely correlated
+1.27%
NVS - SNY
40%
Loosely correlated
+0.94%
PFE - SNY
37%
Loosely correlated
+1.74%
AZN - SNY
37%
Loosely correlated
+1.52%
JNJ - SNY
36%
Loosely correlated
-0.29%
More